Cargando…

Bivalirudin versus heparin in primary PCI: clinical outcomes and cost analysis

BACKGROUND: The evidence for benefits of bivalirudin over heparin has recently been challenged. We aimed to analyse the safety and cost-effectiveness following reintroduction of heparin instead of bivalirudin as the standard anticoagulation for primary percutaneous coronary intervention (PPCI) in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deharo, Pierre, Johnson, Thomas W, Rahbi, Hazim, Kandan, Raveen, Bowles, Ruth, Mozid, Abdul, Dorman, Stephen, Strange, Julian W, Baumbach, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Interventional Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950626/ https://www.ncbi.nlm.nih.gov/pubmed/29765614 http://dx.doi.org/10.1136/openhrt-2017-000767

Ejemplares similares

Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
por: Farag, Mohamed, et al.
Publicado: (2015)

The effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventions
por: Dobies, David R, et al.
Publicado: (2014)

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis
por: Pandit, Anil, et al.
Publicado: (2014)

Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index
por: Dobies, David R, et al.
Publicado: (2015)

Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI
por: Doost Hosseiny, Ataollah, et al.
Publicado: (2016)

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
por: Pufulete, Maria, et al.
Publicado: (2022)

Revascularisation of patients with end-stage renal disease on chronic haemodialysis: bypass surgery versus PCI—analysis of routine statutory health insurance data
por: Möckel, Martin, et al.
Publicado: (2016)

Predicting emergency coronary artery bypass graft following PCI: application of a computational model to refer patients to hospitals with and without onsite surgical backup
por: Syed, Zeeshan, et al.
Publicado: (2015)

GRACE score and cardiovascular outcomes prediction among the delayed coronary intervention after post-fibrinolytic STEMI patients in a limited PCI-capable hospital
por: Chotechuang, Yotsawee, et al.
Publicado: (2020)

The Utility of CT Coronary Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention
por: Yassin, Firas, et al.
Publicado: (2023)

Clinical outcomes and costs of cardiac revascularisation in England and New York state
por: Leyva, Francisco, et al.
Publicado: (2018)

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.
por: Galasso, G, et al.
Publicado: (2016)

Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study
por: Li, Jing, et al.
Publicado: (2022)

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper
por: Johnson, Thomas W, et al.
Publicado: (2014)

Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves
por: Esposito, Giulia, et al.
Publicado: (2022)

Reintroduction of elective cardiac interventions in the era of COVID-19: the Barts experience
por: Hamshere, Stephen, et al.
Publicado: (2021)

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
por: Giuliano, Katherine, et al.
Publicado: (2021)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Percutaneous intervention for symptomatic central vein stenosis in patients with upper limb arteriovenous dialysis access
por: AJ, Ashwal, et al.
Publicado: (2018)

In-hospital outcome of re-attempted percutaneous coronary interventions for chronic total occlusion
por: Guelker, Jan-Erik, et al.
Publicado: (2023)

First clinical experience of high-power ablation of atrial fibrillation with a novel contact force-sensing gold-tip catheter
por: Parwani, Abdul Shokor, et al.
Publicado: (2022)

Impact of frailty on outcomes after percutaneous coronary intervention: a prospective cohort study
por: Murali-Krishnan, Rachel, et al.
Publicado: (2015)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
por: Stephenne, Xavier, et al.
Publicado: (2012)

Non-hyperaemic pressure ratios to guide percutaneous coronary intervention
por: Michail, Michael, et al.
Publicado: (2020)

Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention
por: Wall, Joshua J S, et al.
Publicado: (2017)

Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial
por: Huber, Kurt, et al.
Publicado: (2017)

Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
por: Eftekhari, Ashkan, et al.
Publicado: (2022)

Optical coherence tomography versus intravascular ultrasound to evaluate stent implantation in patients with calcific coronary artery disease
por: Gudmundsdottir, Ingibjorg, et al.
Publicado: (2015)

Longitudinal deformation bench testing using a coronary artery model: a new standard?
por: Choudhury, Tawfiq R, et al.
Publicado: (2017)

Impact of elevated left ventricular filling pressure on long-term outcomes after transcatheter aortic valve replacement
por: Nair, Raunak M, et al.
Publicado: (2022)

Polymer-free sirolimus-eluting stents in a large-scale all-comers population
por: Krackhardt, Florian, et al.
Publicado: (2017)

Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: an observational study
por: Dimitriu-Leen, Aukelien C, et al.
Publicado: (2017)

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome
por: Badings, Erik A, et al.
Publicado: (2017)

Coronary artery height differences and their effect on fractional flow reserve
por: Al-Janabi, Firas, et al.
Publicado: (2021)

Tissue characterisation and primary percutaneous coronary intervention guidance using intravascular ultrasound: rationale and design of the SPECTRUM study
por: Groenland, Frederik T W, et al.
Publicado: (2022)

Distinct Effects of Unfractionated Heparin versus Bivalirudin on Circulating Angiogenic Peptides
por: Kapur, Navin K., et al.
Publicado: (2012)

EFFECT OF HEPARIN AND BIVALIRUDIN ON THE KINETICS OF CLOT FORMATION: VISCOELASTIC COAGULATION TESTING
por: Hasija, Suruchi, et al.
Publicado: (2017)

Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry
por: Jain, Ajay K, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_38aig7k8u5t9kjhrig777kob50